 |
|
Short-term Efficacy of Intravitreal Ranibizumab for Myopic Choroidal Neovascularization.
Min Hye Song, Joon Yong Kim, Young Jung Roh
J Korean Ophthalmol Soc. 2009;50(7):1027-1034. Published online 2009 Jul 15 DOI: https://doi.org/10.3341/jkos.2009.50.7.1027
|
|
Citations to this article as recorded by
 Long-term Treatment Outcomes of Intravitreal Bevacizumab Treatment for Myopic Choroidal Neovascularization
Jeong Min Lee, Jong Woo Kim, Dong Won Lee, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2019; 60(6): 547. CrossRef Risk Factors for Retinal Pigment Epithelium Tears after Anti-VEGF Agent Injection in Age-Related Macular Degeneration
Woo Seok Choae, Jae Hong Park, Woo Seok Lee, Sang Won Kim, Hee Seong Yoon
Journal of the Korean Ophthalmological Society.2013; 54(10): 1546. CrossRef Clinical Effect of Intravitreal Bevacizumab Injection in Myopic Choroidal Neovascularization
Kyong Ho Kim, Jae Ho Jung, Ji Eun Lee, Boo Sup Oum
Journal of the Korean Ophthalmological Society.2010; 51(3): 359. CrossRef
|